Skip to content

SABSW SAB BIOTHERAPEUTICS INC

Follow

SPAC Combination (warrant or right), issuer CIK 1833214

7 managers (7 13F filers) reported a position in SABSW shares at 2025-12-31, 275,542 shares in all. 1 filer opened a position and 4 filers sold out during the quarter.

Managers
7
13F filers
7
New
1
Added
0
Reduced
3
Sold out
4
Shares held by filers
275,542

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2025

Filers in the available 13F reports with a share position at 2025-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
MORGAN STANLEYin group MORGAN STANLEY146,439$4.57K<0.01%013F-HR/ATimelineGroup
Clear Street Group Inc.in group Clear Street Group Inc.78,833$2.46K<0.01%-20013F-HRTimelineGroup
GTS SECURITIES LLC41,101$1.03K<0.01%new13F-HRTimeline
UBS Group AGin group UBS Group AG6,186$192<0.01%-17,22813F-HRTimelineGroup
WOLVERINE ASSET MANAGEMENT LLCin group WOLVERINE ASSET MANAGEMENT LLC1,811$57<0.01%013F-HRTimelineGroup
NewEdge Advisors, LLC1,072$33<0.01%013F-HRTimeline
BANK OF AMERICA CORP /DE/in group BANK OF AMERICA CORP /DE/100$3<0.01%-10013F-HRTimelineGroup